26
Participants
Start Date
April 22, 2019
Primary Completion Date
June 25, 2021
Study Completion Date
August 10, 2021
utidelone injection
utidelone monotherapy in patients with advanced NSCLC by utidelone
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing
Harbin Medical University Cancer Hospital, Harbin
Peking Union Hospital, Beijing
Tianjin People's Hospital, Tianjin
Lead Sponsor
Collaborators (1)
Chengdu Biostar Pharmaceuticals
INDUSTRY
Beijing Biostar Pharmaceuticals Co., Ltd.
INDUSTRY